Features of autoimmunity in cryptogenic chronic hepatitis

Area of Science:

• Hepatology
• Immunology
• Autoimmunity

Background:

• Autoantibodies play a role in chronic liver diseases.
• Accurate detection of autoantibodies is crucial for diagnosis and understanding disease mechanisms.

Purpose of the Study:

• To assess autoantibody presence in patients with cryptogenic chronic hepatitis (CH).
• To compare autoantibody detection using indirect immunofluorescence (IFL) on tissue sections versus Hep-2 cells.
• To evaluate autoantibody patterns in primary biliary cirrhosis (PBC).

Main Methods:

• Indirect immunofluorescence (IFL) assay.
• Analysis of 125 patients with cryptogenic chronic hepatitis (CH).
• Detection of smooth muscle antibodies (SMA), antiactin antibodies, and antinuclear antibodies (ANA) on tissue sections and Hep-2 cells.
• Evaluation of 37 patients with primary biliary cirrhosis (PBC).

Main Results:

• High prevalence of SMA in CH patients, irrespective of anti-HBc status.
• Low frequency of antiactin antibodies, indicative of autoimmunity, in CH.
• Low-titer ANA detected in CH patients and healthy controls using Hep-2 cells.
• Hep-2 cells facilitated better ANA pattern evaluation in PBC, identifying the multiple nuclear dots (MND) pattern in 9 cases.

Conclusions:

• SMA are frequently detected in CH, but antiactin antibodies are less common.
• Hep-2 cells offer improved sensitivity and specificity for ANA detection in chronic liver diseases like CH and PBC.
• The study highlights the utility of Hep-2 cells in identifying specific ANA patterns, aiding in the diagnosis of autoimmune liver conditions.